Tumour-initiating cells (TICs) within most solid tumours, including SCLC,1 are important contributors to disease recurrence, metastasis and therapeutic resistance.2,3 TICs can be identified by a high expression of specific marker proteins, such as CD133, compared with the bulk tumour cell population.4 Here, PROM1 is linked to neoplasm.